Home › Funds › Cornerstone Capital, Inc. › GILD

Cornerstone Capital, Inc. position in GILD

GILEAD SCIENCES INC · Health Care

Cornerstone Capital, Inc. reported holding 35,128 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 0.48% of its reported portfolio and ranking #43 among its reported holdings. Cornerstone Capital, Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)35.13K sh
Reported value held$5.24M
Portfolio Weight0.48%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Cornerstone Capital, Inc.'s GILD position evolved

Cornerstone Capital, Inc. first disclosed a stake in GILD in Q3 2023 at 45,374 shares (US$3.4M). The position peaked in Q3 2026 at 35,128 shares, worth US$5.2M. Across 13 filings, Cornerstone Capital, Inc. increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 35,128 shares valued at US$5.2M — a reduction of -1,030 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 45.37K $3.40M New
Q4 2023 45.37K $3.68M Hold
Q1 2024 39.59K $2.90M Reduce
Q2 2024 35.53K $2.44M Reduce
Q3 2024 35.36K $2.96M Hold
Q4 2024 35.11K $3.24M Reduce
Q1 2025 34.99K $3.92M Hold
Q2 2025 35.54K $3.94M Add
Q3 2025 35.77K $3.97M Add
Q4 2025 35.77K $4.39M Hold
Q1 2026 35.82K $4.99M Hold
Q2 2026 36.16K $4.57M Add
Q3 2026 35.13K $5.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Cornerstone Capital, Inc. held GILD?

Cornerstone Capital, Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cornerstone Capital, Inc.'s current position in GILD?

As of Q3 2026, Cornerstone Capital, Inc. holds 35.13K shares of GILD (GILEAD SCIENCES INC), valued at $5.24M, representing 0.48% of its reported portfolio and ranking #43.

Has Cornerstone Capital, Inc. been buying or selling GILD?

In the latest 13F filing (Q3 2026), Cornerstone Capital, Inc. reduced its position in GILD. The position peaked in Q3 2026 at 35.13K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.